Anemia

Researchers say it's time to treat anemia seriously

Up to one-third of patients undergoing surgery in Ontario have a treatable form of anemia but are not optimally treated for it.

Diseases, Conditions, Syndromes created Jan 24, 2013 | popularity not rated yet | comments 0

New drug improves survival in multiple myeloma relapse

Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for patients with multiple myeloma who have disease relapsed after treatments with ...

Cancer created Jan 24, 2013 | popularity not rated yet | comments 0

Research finds substantial variation in readmission rate among children's hospitals

In a national sample of 72 children's hospitals, 6.5 percent of hospitalized children experienced an unplanned readmission within 30 days, with significant variability in readmission rates across conditions and hospitals, ...

Health created Jan 22, 2013 | popularity not rated yet | comments 0

Researchers find that simple blood test can help identify trauma patients at greatest risk of death

A simple, inexpensive blood test performed on trauma patients upon admission can help doctors easily identify patients at greatest risk of death, according to a new study by researchers at Intermountain Medical Center in ...

Health created Jan 18, 2013 | popularity 5 / 5 (1) | comments 0

Malaria drug association with hemolytic anemia unclear

(HealthDay)—Artesunate, a drug used in the treatment of severe malaria, may or may not be associated with hemolytic anemia, so the U.S. Centers for Disease Control and Prevention recommends close monitoring ...

Diseases, Conditions, Syndromes created Jan 11, 2013 | popularity not rated yet | comments 0

Sickle cell disease, sickle cell trait are not the same

(HealthDay)—Both sickle cell disease and the condition known as sickle cell trait are genetic blood diseases: You're born with one or the other because of the genes inherited from your parents. Beyond that, the two conditions ...

Diseases, Conditions, Syndromes created Dec 28, 2012 | popularity 5 / 5 (1) | comments 0

Amgen to pay record $762 mn fine over anemia drug (Update)

US pharmaceutical giant Amgen has pleaded guilty to illegally introducing a mislabeled drug for treating anemia onto the market and will pay a record $762 million fine, officials said Wednesday.

Medications created Dec 18, 2012 | popularity 5 / 5 (1) | comments 0

Ibrutinib has 'unprecedented' impact on mantle cell lymphoma

An international study of ibrutinib in people with relapsed or refractory mantle cell lymphoma (MCL) continues to show unprecedented and durable results with few side effects.

Cancer created Dec 14, 2012 | popularity not rated yet | comments 0

Researchers highlight potential gene therapy approach to sickle cell disease

Researchers at Dana-Farber/Children's Hospital Cancer Center (DF/CHCC) have taken the first preliminary steps toward developing a form of gene therapy for sickle cell disease. In an abstract presented on Dec. 10 at the 54th ...

Medical research created Dec 11, 2012 | popularity 5 / 5 (3) | comments 0

New multiple myeloma drug shows promise in treating people with advanced disease

A new oral agent under review by the U.S. Food and Drug Administration (FDA) is safe and effective in treating relapsed and treatment-resistant multiple myeloma, according to a multicenter, Phase II study presented by Mount ...

Cancer created Dec 10, 2012 | popularity 5 / 5 (1) | comments 0

More than a third of high-risk leukemia patients respond to an experimental new drug

A new drug for patients with acute myeloid leukemia (AML) marked by a specific type of genetic mutation has shown surprising promise in a Phase II clinical trial. In more than a third of participants, the leukemia was completely ...

Medications created Dec 09, 2012 | popularity not rated yet | comments 0

Genotype predicts treatment related mortality (TRM) in African-American and Asian pediatric AML patients

New research suggests that the presence of a specific genetic marker, known as WT1 SNP rs16754, may be associated with reduced toxicity from chemotherapy in African-American and Asian children with acute myeloid leukemia ...

Cancer created Dec 09, 2012 | popularity not rated yet | comments 0

Upper endoscopy is overused in patients with heartburn

Heartburn is one of the most common reasons for people to see a doctor, and some physicians often use upper endoscopy to diagnose and manage gastroesophageal reflux disease (GERD). But most patients do not require the procedure ...

Diseases, Conditions, Syndromes created Dec 03, 2012 | popularity not rated yet | comments 0

ACOG: Delaying cord clamping advised for preterm infants

(HealthDay)—Evidence supports the benefits of delayed umbilical cord clamping for preterm infants, while for term infants, the evidence is unclear, according to a Committee Opinion published in the December ...

Obstetrics & gynaecology created Dec 03, 2012 | popularity not rated yet | comments 0

Treatment for snail-borne schistosomiasis works best over the long haul

Watch where you jump in for a swim or where your bath water comes from, especially if you live in Africa, Asia or South America. Snails that live in tropical freshwater in these locations are intermediaries ...

Diseases, Conditions, Syndromes created Nov 20, 2012 | popularity not rated yet | comments 0


Anemia (/əˈniːmiə/; also spelled anaemia and anæmia; from Greek ἀναιμία anaimia, meaning lack of blood) is a decrease in number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency.

Because hemoglobin (found inside RBCs) normally carries oxygen from the lungs to the tissues, anemia leads to hypoxia (lack of oxygen) in organs. Since all human cells depend on oxygen for survival, varying degrees of anemia can have a wide range of clinical consequences.

Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis).

There are two major approaches: the "kinetic" approach which involves evaluating production, destruction and loss, and the "morphologic" approach which groups anemia by red blood cell size. The morphologic approach uses a quickly available and low cost lab test as its starting point (the MCV). On the other hand, focusing early on the question of production may allow the clinician to expose cases more rapidly where multiple causes of anemia coexist.

This text uses material from Wikipedia and is available under the GNU Free Documentation License.

Latest Spotlight News

New research identifies risks, interventions for children's GI health

An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).

AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Body clocks of depressed people altered at cell level, researchers show

Every cell in our bodies runs on a 24-hour clock, tuned to the night-day, light-dark cycles that have ruled us since the dawn of humanity. The brain acts as timekeeper, keeping the cellular clock in sync ...

Human brain frontal lobes not relatively large, not sole center of intelligence

Human intelligence cannot be explained by the size of the brain's frontal lobes, say researchers.

Returning genetic incidental findings without patient consent violates basic rights, experts say

Informed consent is the backbone of patient care. Genetic testing has long required patient consent and patients have had a "right not to know" the results. However, as 21st century medicine now begins to use the tools of ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Vicious cycle: Obesity sustained by changes in brain biochemistry

With obesity reaching epidemic levels in some parts of the world, scientists have only begun to understand why it is such a persistent condition. A study in the Journal of Biological Chemistry adds substantially to the st ...

White matter imaging provides insight into human and chimpanzee aging

(Medical Xpress)—The instability of "white matter" in humans may contribute to greater cognitive decline during the aging of humans compared with chimpanzees, scientists from Yerkes National Primate Research ...